Drug class
Tetracycline-class antibacterial; 30S ribosomal protein-synthesis inhibitor
Mechanism of action
Reversibly binds to the bacterial 30S ribosomal subunit and prevents aminoacyl-tRNA from binding to the acceptor site on the mRNA-ribosome complex, inhibiting bacterial protein synthesis and producing bacteriostatic activity.
General use cases
- Treatment of susceptible bacterial infections in countries where metacycline is authorised; indication depends on local product information and susceptibility.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
